PSYBF (PsyBio Therapeutics) Other Current Payables: $0.45 Mil (As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is PsyBio Therapeutics Other Current Payables?

PsyBio Therapeutics PSYBF -90.00% Other Current Payables is $0.45 Mil as of Jun. 2023.

PsyBio Therapeutics's Other Current Payables for the quarter that ended in Jun. 2023 was $0.45 Mil.

PsyBio Therapeutics's quarterly Other Current Payables stayed the same from Dec. 2022 ($0.45 Mil) to Mar. 2023 ($0.45 Mil) but then increased from Mar. 2023 ($0.45 Mil) to Jun. 2023 ($0.45 Mil).

PsyBio Therapeutics's annual Other Current Payables increased from . 20 ($0.00 Mil) to Dec. 2021 ($0.50 Mil) but then declined from Dec. 2021 ($0.50 Mil) to Dec. 2022 ($0.45 Mil).

PsyBio Therapeutics Other Current Payables Related Terms

PsyBio Therapeutics Other Current Payables Historical Data

* Premium members only.

The historical data trend for PsyBio Therapeutics's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PsyBio Therapeutics Other Current Payables Chart

PsyBio Therapeutics Annual Data
Trend Dec21 Dec22
Other Current Payables
0.50 0.45

PsyBio Therapeutics Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.45 0.45 0.45 0.45 0.45

PsyBio Therapeutics Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $0.45 Mil mean?
PsyBio Therapeutics (PSYBF) has a Other Current Payables of $0.45 Mil as of Jun. 2023. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on PsyBio Therapeutics and its competitors.
Is PsyBio Therapeutics' Other Current Payables too high?
PsyBio Therapeutics' current Other Current Payables is $0.45 Mil.
How does PsyBio Therapeutics' Other Current Payables compare to VRTX and REGN?
PsyBio Therapeutics' Other Current Payables of $0.45 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on PsyBio Therapeutics and its competitors. PsyBio Therapeutics's current Other Current Payables is $0.45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PsyBio Therapeutics stock overvalued right now?
PsyBio Therapeutics (PSYBF) has a current Other Current Payables of $0.45 Mil. The current Other Current Payables is $0.45 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For PsyBio Therapeutics (PSYBF), the current Other Current Payables is $0.45 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PsyBio Therapeutics Business Description

Address 1624 Washington Street, Denver, CO, USA, 80203
PsyBio Therapeutics Corp is a biotechnology company. The company is engaged in the development of drugs intended for the treatment of mental illness and neurological disorders.